NEUPHORIA THERAPEUTICS INC (NEUP) Stock Earnings & Estimates
NASDAQ:NEUP - US64136E1029 - Common Stock
13.92 USD
-1.18 (-7.78%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 169.9K | 22.1K -86.99% | 950.487K 4,200.85% | -100.00% | N/A | |
| EBITDA YoY % growth | N/A -253.57% | N/A | -32.299M | -23.328M 27.78% | -17.034M 26.98% | N/A | |
| EBIT YoY % growth | -5.591M -111.72% | -14.349M -156.63% | -32.963M -129.71% | -21.855M 33.70% | -17.034M 22.06% | -30.702M | |
| Operating Margin | N/A | -8,445.79% | -149,152.49% | -2,299.38% | N/A | N/A | |
| EPS YoY % growth | -0.01 -87.46% | -0.02 -130.00% | N/A -104,017.17% | -1.32 94.49% | -11.73 -788.37% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | |
|---|---|---|
| EPS Q2Q % growth | -0.57 | -0.56 |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | -5.202M 69.81% | -5.304M -55.91% |
| EBIT Q2Q % growth | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -2.00% | -0.01 | % | |
| Q2 2023 Q2Q % growth | -0.01 7.69% | -0.01 | 0.00 | -17.65% |
| Q4 2022 Q2Q % growth | -0.01 | -7.59 | 7.58 | 99.87% |
| Q2 2022 Q2Q % growth | -0.01 | -0.74 | 0.73 | 98.25% |
| Q4 2021 Q2Q % growth | -0.01 -1,049.43% | 0.00 | -0.01 | -164.97% |
| Q4 2020 Q2Q % growth | 0.00 -150.00% | -0.01 | 0.01 | 90.21% |
| Q4 2019 Q2Q % growth | 0.00 | -0.01 | 0.01 | 119.59% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | 22.1K -87.49% | 8.874M | -8.852M | -99.75% |
| Q2 2023 Q2Q % growth | 5.916M | -5.916M | -100.00% | |
| Q4 2022 Q2Q % growth | 176.7K | 297.677K | -120.977K | -40.64% |
| Q2 2022 Q2Q % growth | -100.00% | 2.448M | -2.448M | -100.00% |
| Q4 2021 Q2Q % growth | -100.00% | 4.488M | -4.488M | -100.00% |
| Q2 2021 Q2Q % growth | 101.5K 1.20% | 4.386M | -4.285M | -97.69% |
| Q4 2020 Q2Q % growth | 46.7K -82.26% | 2.417M | -2.37M | -98.07% |
| Q2 2020 Q2Q % growth | 100.3K -84.40% | % | ||
| Q4 2019 Q2Q % growth | 263.3K | 5.641M | -5.378M | -95.33% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |